Working memory and the homeostatic control of brain adenosine by adenosine kinase

Neuroscience

Volumn 213, Issue , 2012, Pages 81-92

  Singer, P ^a,b   McGarrity, S ^a,c   Shen, H Y ^b   Boison, D ^b   Yee, B K ^a,b  

^a ETH ZURICH   (Switzerland)

^b LEGACY RESEARCH   (United States)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

A 1R; A 2AR; Adenosine; Adk; Adk tg; Anova; Ar; Caffeine; Fb Adk Tg; Glutamate; Iti; Learning; Ltp; Mglur5; Nmda receptor; Nmdar; Radial arm maze; Ram; Se; Wt

Indexed keywords

ADENOSINE; ADENOSINE KINASE; ADENOSINE RECEPTOR; CAFFEINE; DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

AMNESIA; ANIMAL EXPERIMENT; ARTICLE; BRAIN CORTEX; BRAIN REGION; COGNITIVE DEFECT; CONTROLLED STUDY; HABITUATION; HIPPOCAMPUS; HOMEOSTASIS; LEARNING; MOUSE; NEUROMODULATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPATIAL MEMORY; TELENCEPHALON; UPREGULATION; WORKING MEMORY;

ADENOSINE; ADENOSINE KINASE; ANIMALS; BRAIN; HOMEOSTASIS; MAZE LEARNING; MEMORY, SHORT-TERM; MICE; MICE, MUTANT STRAINS; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 84861671688     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2012.03.051     Document Type: Article

References (66)

1. Arai A., Kessler M., Lynch G. The effects of adenosine on the development of long-term potentiation. Neurosci Lett 1990, 119:41-44.
2. Baddeley A. Working memory: looking back and looking forward. Nat Rev Neurosci 2003, 4:829-839.
3. Barch D.M., Smith E. The cognitive neuroscience of working memory: relevance to CNTRICS and schizophrenia. Biol Psychiatry 2008, 64:11-17.
4. Boison D. Adenosine kinase, epilepsy and stroke: mechanisms and therapies. Trends Pharmacol Sci 2006, 12:652-658.
5. Boison D. Cell and gene therapies for refractory epilepsy. Curr Neuropharmacol 2007, 5:115-125.
6. Boison D. Adenosine as a neuromodulator in neurological diseases. Curr Opin Pharmacol 2008, 8:2-7.
7. Boison D., Chen J.F., Fredholm B.B. Adenosine signaling and function in glial cells. Cell Death Differ 2010, 17:1071-1082.
8. Boison D., Singer P., Shen H.Y., Feldon J., Yee B.K. Adenosine hypothesis of schizophrenia - opportunities for pharmacotherapy. Neuropharmacology 2012, 62:1527-1543.
9. Capek S., Guenther R.K. Caffeine's effects on true and false memory. Psychol Rep 2009, 104:787-795.
10. Carlsson M.L. Are the disparate pharmacological profiles of competitive and un competitive NMDA antagonists due to different baseline activities of distinct glutamatergic pathways? (Hypothesis). J Neural Transm Gen Sect 1993, 94:1-10.
11. Cestari V., Castellano C. Caffeine and cocaine interaction on memory consolidation in mice. Arch Int Pharmacodyn Ther 1996, 331:94-104.
12. Chen J.F., Yu L., Shen H.Y., He J.C., Wang X., Zheng R. What knock-out animals tell us about the effects of caffeine. J Alzheimers Dis 2010, 20(Suppl. 1):S17-S24.
13. Corodimas K.P., Pruitt J.C., Stieg J.M. Acute exposure to caffeine selectively disrupts context conditioning in rats. Psychopharmacology (Berl) 2000, 152:376-382.
14. Costa M.S., Botton P.H., Mioranzza S., Ardais A.P., Moreira J.D., Souza D.O., Porciúncula L.O. Caffeine improves adult mice performance in the object recognition task and increases BDNF and TrkB independent on phospho-CREB immunocontent in the hippocampus. Neurochem Int 2008, 53:89-94.
15. Costenla A.R., Cunha R.A., de Mendonça A. Caffeine, adenosine receptors, and synaptic plasticity. J Alzheimers Dis 2010, 20(Suppl. 1):S25-S34.
16. Cunha R.A. Different cellular sources and different roles of adenosine: A1 receptor-mediated inhibition through astrocytic-driven volume transmission and synapse-restricted A2A receptor-mediated facilitation of plasticity. Neurochem Int 2008, 52:65-72.
17. Cunha R.A., Agostinho P.M. Chronic caffeine consumption prevents memory disturbance in different animal models of memory decline. J Alzheimers Dis 2010, 20(Suppl. 1):S95-S116.
18. deMendonca A., Ribeiro J.A. Adenosine and synaptic plasticity. Drug Dev Res 2001, 52:283-290.
19. Etherington L.A., Patterson G.E., Meechan L., Boison D., Irving A.J., Dale N., Frenguelli B. Astrocytic adenosine kinase regulates basal synaptic adenosine levels and seizure activity but not activity-dependent adenosine release in the hippocampus. Neuropharmacology 2009, 56:429-437.
20. Fedele D.E., Gouder N., Güttinger M., Gabernet L., Scheurer L., Rülicke T., Crestani F., Boison D. Astrogliosis in epilepsy leads to overexpression of adenosine kinase resulting in seizure aggravation. Brain 2005, 128:2383-2395.
21. Fredholm B.B., Bättig K., Holmén J., Nehlig A., Zvartau E.E. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev 1999, 51:83-133.
22. Fredholm B.B., Chen J.F., Cunha R.A., Svenningsson P., Vaugeois J.M. Adenosine and brain function. Int Rev Neurobiol 2005, 63:191-270.
23. Fuxe K., Ferré S., Zoli M., Agnati L.F. Integrated events in central dopamine transmission as analyzed at multiple levels. Evidence for intramembrane adenosine A2A/dopamine D2 and adenosine A1/dopamine D1 receptor interactions in the basal ganglia. Brain Res Rev 1998, 26:258-273.
24. Giménez-Llort L., Schiffmann S.N., Shmidt T., Canela L., Camon L., Wassholm M., Canals M., Terasmaa A., Fernandez-Teruel A., Tobeña A., Popova E., Ferré S., Agnati L., Ciruela F., Martínez E., Scheel-Kruger J., Lluis C., Franco R., Fuxe K., Bader M. Working memory deficits in transgenic rats overexpressing human adenosine A2A receptors in the brain. Neurobiol Learn Mem 2007, 87:42-56.
25. Guillet R., Kellogg C. Neonatal exposure to therapeutic caffeine alters the ontogeny of adenosine A1 receptors in brain of rats. Neuropharmacology 1991, 30:489-496.
26. Holtzman S.G., Mante S., Minneman K.P. Role of adenosine receptors in caffeine tolerance. J Pharmacol Exp Ther 1991, 256:62-68.
27. Iwasato T., Nomura R., Ando R., Ikeda T., Tanaka M., Itohara S. Dorsal telencephalon-specific expression of Crerecombinase in PAC transgenic mice. Genesis 2004, 38:130-138.
28. Jacobson K.A., von Lubitz D.K., Daly J.W., Fredholm B.B. Adenosine receptor ligands: differences with acute versus chronic treatment. Trends Pharmacol Sci 1996, 17:108-113.
29. Johansson B., Georgiev V., Lindstrom K., Fredholm B.B. A1 and A2A adenosine receptors and A1 mRNA in mouse brain: effect of long-term caffeine treatment. Brain Res 1997, 762:153-164.
30. Kant G.J. Effects of psychoactive drugs or stress on learning, memory, and performance as assessed using a novel water maze task. Pharmacol Biochem Behav 1993, 44:287-295.
31. Kopf S.R., Melani A., Pedata F., Pepeu G. Adenosine and memory storage: effect of A(1) and A(2) receptor antagonists. Psychopharmacology (Berl) 1999, 146:214-219.
32. Lara D.R., Dall'Igna O.P., Ghisolfi E.S., Brunstein M.G. Involvement of adenosine in the neurobiology of schizophrenia and its therapeutic implications. Prog Neuropsychopharmacol Biol Psychiatry 2006, 30:617-629.
33. Lee J., Park S. Working memory impairments in schizophrenia: a meta-analysis. J Abnorm Psychol 2005, 114:599-611.
34. Li T., Ren G., Lusardi T., Wilz A., Lan J.Q., Iwasato T., Itohara S., Simon R.P., Boison D. Adenosine kinase is a target for the prediction and prevention of epileptogenesis in mice. J Clin Invest 2008, 118:571-582.
35. Lopez L., Hauser J., Feldon J., Gargiulo P.A., Yee B.K. Evaluating spatial memory function in mice: a within-subjects comparison between the water maze test and its adaptation to dry land. Behav Brain Res 2010, 209:85-92.
36. Lyon L., Burnet P.W., Kew J.N., Corti C., Rawlins J.N., Lane T., De Filippis B., Harrison P.J., Bannerman D.M. Fractionation of spatial memory in GRM2/3 (mGlu2/mGlu3) double knockout mice reveals a role for group II metabotropic glutamate receptors at the interface between arousal and cognition. Neuropsychopharmacology 2011, 36:2616-2628.
37. Nakazawa K., Quirk M.C., Chitwood R.A., Watanabe M., Yeckel M.F., Sun L.D., Kato A., Carr C.A., Johnston D., Wilson M.A., Tonegawa S. Requirement for hippocampal CA3 NMDA receptors in acquisition and recall of associative memory. Science 2002, 297:211-218.
38. Nakazawa K., Sun L.D., Quirk M.C., Rondi-Reig L., Wilson M.A., Tonegawa S. Hippocampal CA3 NMDA receptors are crucial for memory acquisition of one-time experience. Neuron 2003, 38:305-315.
39. Nehlig A. Is caffeine a cognitive enhancer?. J Alzheimers Dis 2010, 20(Suppl. 1):S85-S94.
40. Nehlig A., Daval J.L., Debry G. Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects. Brain Res Brain Res Rev 1992, 17:139-170.
41. Ohno M., Watanabe S. Working memory failure by stimulation of hippocampal adenosine A1 receptors in rats. Neuroreport 1996, 7:3013-3016.
42. Park S., Holzman P.S. Schizophrenics show spatial working memory deficits. Arch Gen Psychiatry 1992, 49:975-982.
43. Pietropaolo S., Sun Y., Li R., Brana C., Feldon J., Yee B.K. Limited impact of social isolation on Alzheimer-like symptoms in a triple transgenic mouse model. Behav Neurosci 2009, 123:181-195.
44. Postle B.R. Working memory as an emergent property of the mind and brain. Neuroscience 2006, 139:23-38.
45. Prediger R.D., Pamplona F.A., Fernandes D., Takahashi R.N. Caffeine improves spatial learning deficits in an animal model of attention deficit hyperactivity disorder (ADHD) and the spontaneously hypertensive rat (SHR). Int J Neuropsychopharmacol 2005, 8:583-594.
46. Prediger R.D., Takahashi R.N. Modulation of short-term social memory in rats by adenosine A1 and A(2A) receptors. Neurosci Lett 2005, 376:160-165.
47. Rebola N., Lujan R., Cunha R.A., Mulle C. Adenosine A2A receptors are essential for long-term potentiation of NMDA-EPSCs at hippocampal mossy fiber synapses. Neuron 2008, 57:121-134.
48. Reisel D., Bannerman D.M., Schmitt W.B., Deacon R.M., Flint J., Borchardt T., Seeburg P.H., Rawlins J.N. Spatial memory dissociations in mice lacking GluR1. Nat Neurosci 2002, 5:868-873.
49. Ribeiro J.A., Sebastião A.M. Caffeine and adenosine. J Alzheimers Dis 2010, 20(Suppl. 1):S3-S15.
50. Ribeiro JA., Sebastião AM., de Mendonça A. Adenosine receptors in the nervous system: pathophysiological implications. Prog Neurobiol 2003, 68:377-392.
51. Sanderson D.J., Gray A., Simon A., Taylor A.M., Deacon R.M., Seeburg P.H., Sprengel R., Good M.A., Rawlins J.N., Bannerman D.M. Deletion of glutamate receptor-A (GluR-A) AMPA receptor subunits impairs one-trial spatial memory. Behav Neurosci 2007, 121:559-569.
52. Sanderson D.J., McHugh S.B., Good M.A., Sprengel R., Seeburg P.H., Rawlins J.N., Bannerman D.M. Spatial working memory deficits in GluA1 AMPA receptor subunit knockout mice reflect impaired short-term habituation: evidence for Wagner's dual-process memory model. Neuropsychologia 2010, 48:2303-2315.
53. Ribeiro J.A., Sebastião A.M. Adenosine receptors and the central nervous system. Handb Exp Pharmacol 2009, 193:471-534.
54. Shen H.Y., Lusardi T.A., Williams-Karnesky R.L., Lan J.Q., Poulsen D.J., Boison D. Adenosine kinase determines the degree of brain injury after ischemic stroke in mice. J Cereb Blood Flow Metab 2011, 31:1648-1659.
55. Singer P., Feldon J., Yee B.K. The glycine transporter 1 inhibitor SSR504734 enhances working memory performance in a continuous delayed alternation task in C57BL/6 mice. Psychopharmacology (Berl) 2009, 202:371-384.
56. Stone T.W., Collis M.G., Williams M., Miller L.P., Karasawa A., Hillaire-Buys D. Adenosine: some therapeutic applications and prospects. Pharmacological sciences: perspectives for research and therapy in the late 1990s 1995, 303-309. Birkhäuser Verlag, Basel. A.C. Cuello, B. Collier (Eds.).
57. Studer F.E., Fedele D.E., Marowsky A., Schwerdel C., Wernli K., Vogt K., Fritschy J.M., Boison D. Shift of adenosine kinase expression from neurons to astrocytes during postnatal development suggests dual functionality of the enzyme. Neuroscience 2006, 142:125-137.
58. Svenningsson P., Nomikos G.G., Fredholm B.B. The stimulatory action and the development of tolerance to caffeine is associated with alterations in gene expression in specific brain regions. J Neurosci 1999, 19:4011-4022.
59. Takahashi R.N., Pamplona F.A., Prediger R.D. Adenosine receptor antagonists for cognitive dysfunction: a review of animal studies. Front Biosci 2008, 13:2614-2632.
60. Takahata R., Moghaddam B. Activation of glutamate neurotransmission in the prefrontal cortex sustains the motoric and dopaminergic effects of phencyclidine. Neuropsychopharmacology 2003, 28:1117-1124.
61. Wei C.J., Singer P., Coelho J., Boison D., Feldon J., Yee B.K., Chen J.F. Selective inactivation of adenosine A2A receptors in striatal neurons enhances working memory and reversal learning. Learn Mem 2011, 18:459-474.
62. Yee B.K., Balic E., Singer P., Schwerdel C., Grampp T., Gabernet L., Knuesel I., Benke D., Feldon J., Mohler H., Boison D. Disruption of glycine transporter 1 restricted to forebrain neurons is associated with a pro-cognitive and antipsychotic phenotypic profile. J Neurosci 2006, 26:3169-3181.
63. Yee B.K., Singer P., Chen J.F., Feldon J., Boison D. Transgenic overexpression of adenosine kinase in brain leads to multiple learning impairments and altered sensitivity to psychomimetic drugs. Eur J Neurosci 2007, 26:3237-3252.
64. Yerkes R.M., Dodson J.D. The relation of strength of stimulus to rapidity of habit formation. J Comp Neurol Psychol 1908, 18:459-482.
65. Yonkov D.I. Possible role of brain dopaminergic systems in the memory effects of central stimulants. Methods Find Exp Clin Pharmacol 1984, 6:235-239.
66. Zimmerberg B., Carr K.L., Scott A., Lee H.H., Wieder J.M. The effects of postnatal caffeine exposure on growth, activity and learning in rats. Pharmacol Biochem Behav 1991, 39:883-888.